Literature DB >> 9186949

Expression of the nonstructural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera.

I Birch-Machin1, A Rowan, J Pick, J Mumford, M Binns.   

Abstract

The nucleotide sequence of the nonstructural protein NS1 of the influenza virus A/equine 2/Suffolk/89 was determined and found to be 97% identical to that of A/equine 2/Miami/63. A similar level of identity was shown for the deduced NS1 amino acid sequence. The NS1 gene was expressed, in its entirety and in part, as fusion proteins with glutathione S-transferase using the pGEX-3X expression vector. Antibodies to NS1 protein were detected in serum samples from ponies experimentally infected with influenza virus, but not in animals vaccinated with whole inactivated virus or in unprimed control animals. The antigenic determinant(s) of NS1 protein appear to be located in the C-terminal half of the protein. The implications of these findings are discussed with reference to the use of NS1 protein as a differential diagnostic marker for influenza virus infection in the presence of high levels of circulating antibody to influenza haemagglutinin generated by recent vaccination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9186949     DOI: 10.1016/s0166-0934(97)02189-7

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  9 in total

1.  Field application of the H9M2e enzyme-linked immunosorbent assay for differentiation of H9N2 avian influenza virus-infected chickens from vaccinated chickens.

Authors:  Min-Chul Kim; Jun-Gu Choi; Ji-Sun Kwon; Hyun-Mi Kang; Mi-Ra Paek; Ok-Mi Jeong; Jun-Hun Kwon; Youn-Jeong Lee
Journal:  Clin Vaccine Immunol       Date:  2010-10-27

2.  Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice.

Authors:  B Ferko; J Stasakova; S Sereinig; J Romanova; D Katinger; B Niebler; H Katinger; A Egorov
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

3.  Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus.

Authors:  Terrence M Tumpey; Rene Alvarez; David E Swayne; David L Suarez
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

4.  Influenza A virus NS1 induces G0/G1 cell cycle arrest by inhibiting the expression and activity of RhoA protein.

Authors:  Wei Jiang; Qingtao Wang; Shuai Chen; Shijuan Gao; Liping Song; Pengyu Liu; Wenlin Huang
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

5.  Antibodies to PB1-F2 protein are induced in response to influenza A virus infection.

Authors:  Ingrid Krejnusová; Hana Gocníková; Magdaléna Bystrická; Hana Blaskovicová; Katarína Poláková; Jonathan Yewdell; Jack Bennink; Gustáv Russ
Journal:  Arch Virol       Date:  2009-08-12       Impact factor: 2.574

6.  Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines.

Authors:  Chun I Yu; Michael Gallegos; Florentina Marches; Gerard Zurawski; Octavio Ramilo; Adolfo García-Sastre; Jacques Banchereau; A Karolina Palucka
Journal:  Blood       Date:  2008-08-19       Impact factor: 22.113

7.  A Closer Look at the NS1 of Influenza Virus.

Authors:  William G Dundon; Ilaria Capua
Journal:  Viruses       Date:  2009-11-26       Impact factor: 5.048

Review 8.  Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use.

Authors:  Aitor Nogales; Marta L DeDiego; Luis Martínez-Sobrido
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

9.  Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.

Authors:  Zhihao Sun; Qiuxia Wang; Gang Li; Jingzhi Li; Sujuan Chen; Tao Qin; Hongwei Ma; Daxin Peng; Xiufan Liu
Journal:  Microbiol Spectr       Date:  2021-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.